Dynamic cardiomyoplasty: indication, surgical technique, and results

Area of Science:

• Cardiovascular Surgery
• Heart Failure Management
• Medical Technology Assessment

Background:

• Dynamic cardiomyoplasty (DCM) efficacy remains debated despite over 400 global procedures.
• Standardized indications and techniques now allow for comparable multi-center results.
• DCM is primarily considered for patients with contraindications to heart transplantation.

Purpose of the Study:

• To evaluate the clinical and hemodynamic outcomes of dynamic cardiomyoplasty in patients unsuitable for heart transplantation.
• To assess the long-term efficacy and safety of DCM in a cohort with advanced heart failure.

Main Methods:

• Retrospective analysis of 8 isolated dynamic cardiomyoplasty procedures performed between August 1990 and October 1994.
• Inclusion criteria: cardiomyopathy (EF 14-32%, NYHA III) with contraindications for heart transplantation.
• Follow-up included clinical assessment, echocardiography, pulmonary function tests, and treadmill testing.

Main Results:

• Significant symptomatic improvement in 6 of 7 patients (86%), with 3 returning to work.
• Left Ventricular Ejection Fraction (LVEF) increased significantly from baseline (21.2%) to 38.1% at 1 year (p < 0.015).
• Pulmonary artery pressure showed a trend towards decrease; no significant changes in lung function or exercise capacity were observed.

Conclusions:

• Dynamic cardiomyoplasty can yield considerable clinical improvement in carefully selected heart failure patients.
• Objective hemodynamic and functional improvements are less striking than symptomatic gains.
• DCM serves as a viable option for patients with contraindications to heart transplantation, not as an alternative to it.